EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bioactive Indanes: Design, synthesis and bioactivity investigation of 2,2-substituted Indane derivatives, a new bioactive Indane scaffold

Tao Zhang, Kit Chan, Abdulilah Ece, Robin Daly, Aoife Cannon, Gaia A Scalabrino, Neil Frankish, Jacintha O'Sullivan, Padraig Fallon, Helen Sheridan

Bioorganic Chemistry · 2025-06 · 159 · 108352

DOI: 10.1016/j.bioorg.2025.108352 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2025-06. Verfasst von Tao Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Food Science and Environmental Health, Technological University Dublin, Grangegorman, Dublin 7, Ireland; Trino Therapeutics Ltd, The Tower,…. Hauptthemen laut MEDLINE: Indans, Lipoxygenase Inhibitors, Drug Design, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Trinity College Dublin, Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The indane scaffold, prevalent in bioactive natural products, underpins numerous therapeutics. Our group developed a series of 1,2-indane dimers, including PH46A (9), for inflammatory and autoimmune diseases. This study details the design, synthesis and characterisation of 21 compounds, including 2,2-disubstituted indanones (16a-16h), indanols (17a-17h), and indanes (18a-18h). These compounds were tested in vitro and in vivo using the murine dextran sulphate sodium (DSS) model of inflammatory bowel disease (IBD). Cytotoxicity screening in THP-1 macrophages and SW480 cells revealed increased cytotoxicity with indene ring substitution at C2, with 18d emerging as potent. In lipoxygenase (LOX) assays, 18a, 18d, and 18c exhibited significant 5-LOX inhibition, with 18d comparable to zileuton. Selective 5-LOX inhibition over 15-LOX indicated distinct ligand-isozyme interactions, potentially informing novel inhibitor development. Cytokine profiling identified compounds with optimal C1 and C2 substituents, particularly 18d, which inhibited IL-6, IL-1β, TNF-α, and IFN-γ in THP-1 macrophages and IL-8 in SW480 cells. In vivo DSS colitis model testing showed significant disease activity index reduction (p < 0.01) with 18d. Subsequent to molecular docking, molecular docking simulations predicted stable binding of 18c and 18d to 5-LOX under mimicked physiological conditions. These findings offer insights into indane-based therapeutic drug development for IBD, highlighting cost reductions by minimising stereochemistry complexity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IndansLipoxygenase InhibitorsDrug DesignInflammatory Bowel DiseasesAnti-Inflammatory Agents, Non-SteroidalHumansStructure-Activity RelationshipAnimalsMiceArachidonate 5-LipoxygenaseMolecular StructureDose-Response Relationship, DrugDextran SulfateColitisMolecular Docking SimulationArachidonate 15-LipoxygenaseCytokines

Stichwörter der Autor:innen

5-LOX inhibitorsBi-benzyl indanesCytotoxicity screeningInflammatory bowel disease (IBD)Molecular dynamicsStructure-activity relationships

Substanzen

IndansLipoxygenase InhibitorsArachidonate 5-LipoxygenaseDextran SulfateArachidonate 15-LipoxygenaseCytokinesAnti-Inflammatory Agents, Non-Steroidal

Autor:innen und Institutionen

  • School of Food Science and Environmental Health, Technological University Dublin, Grangegorman, Dublin 7, Ireland; Trino Therapeutics Ltd, The Tower, Trinity Technology and Enterprise Campus, Dublin 2, Ireland.; Drug Di…
  • Drug Discovery Group, School of Pharmacy and Pharmaceutical Sciences and Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland. Electronic address: chanki@tcd.ie.
  • Department of Medical Biochemistry, Faculty of Medicine, Biruni University, İstanbul TR-34015, Türkiye. Electronic address: aece@biruni.edu.tr.
  • Drug Discovery Group, School of Pharmacy and Pharmaceutical Sciences and Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland. Electronic address: dalyro@tcd.ie.
  • Trinity St. James's Cancer Institute, Trinity Translational Medicine Institute, St. James's Hospital, Dublin 8, Ireland. Electronic address: cannona@tcd.ie.
  • Trino Therapeutics Ltd, The Tower, Trinity Technology and Enterprise Campus, Dublin 2, Ireland.; The Trinity Centre for Natural Products Research (NatPro), School of Pharmacy and Pharmaceutical Sciences, Trinity College…

Förderung

  • Trinity College Dublin
  • Wellcome Trust

Zitieren

APA

Zhang, T., Chan, K., Ece, A., Daly, R., Cannon, A., Scalabrino, G. A., Frankish, N., O'Sullivan, J., Fallon, P., & Sheridan, H. (2025). Bioactive Indanes: Design, synthesis and bioactivity investigation of 2,2-substituted Indane derivatives, a new bioactive Indane scaffold. Bioorganic Chemistry, 159, 108352. https://doi.org/10.1016/j.bioorg.2025.108352

Vancouver

Zhang T, Chan K, Ece A, Daly R, Cannon A, Scalabrino GA, et al. Bioactive Indanes: Design, synthesis and bioactivity investigation of 2,2-substituted Indane derivatives, a new bioactive Indane scaffold. Bioorganic Chemistry. 2025;159:108352. doi:10.1016/j.bioorg.2025.108352

BibTeX
@article{Zhang2025,
  author = {Zhang, Tao and Chan, Kit and Ece, Abdulilah and Daly, Robin and Cannon, Aoife and Scalabrino, Gaia A and Frankish, Neil and O'Sullivan, Jacintha and Fallon, Padraig and Sheridan, Helen},
  title = {Bioactive Indanes: Design, synthesis and bioactivity investigation of 2,2-substituted Indane derivatives, a new bioactive Indane scaffold},
  journal = {Bioorganic Chemistry},
  year = {2025},
  volume = {159},
  pages = {108352},
  doi = {10.1016/j.bioorg.2025.108352}
}
Kostenlos starten →